Advances in End-Stage Renal Diseases 2001: International Conference on Dialysis Iii, Miami Beach, Fla., January 2001

Contents......Page 4
Preface......Page 6
Arterial Functions......Page 8
Arterial Remodeling and Function in ESRD......Page 9
Acknowledgments......Page 10
References......Page 11
Traditional Risk Factors Are Inadequate as Predictors of Cardiovascular Mortality in Dialysis Patients......Page 12
Are There Two Types of Malnutrition in Dialysis Patients?......Page 13
Inflammation Is a Common Feature of Chronic Renal Failure......Page 15
Does Chronic Inflammation Cause Atherosclerotic Cardiovascular Disease?......Page 16
Inflammation and Insulin Resistance......Page 17
Acknowledgements......Page 18
References......Page 19
Background Considerations......Page 21
Evidence of Differences in Outcomes......Page 22
Nonactionable Factors and Patients\' Outcomes......Page 23
Outcomes and Processes of Clinical Care......Page 24
References......Page 25
Why Do We Aim for Subnormal Hematocrit Levels?......Page 26
Normalization of Hemoglobin in Dialysis Patients......Page 27
Why Should Hemoglobin Not Be Normalized in Dialysis Patients?......Page 30
Normalization of Hemoglobin in Pre-ESRD Patients......Page 34
References......Page 35
Introduction......Page 37
Cardiovascular Function......Page 38
Physical Activity......Page 40
Conclusions......Page 41
References......Page 42
Early Initiation......Page 44
Hemodialysis or Peritoneal Dialysis for Incremental Dialysis?......Page 45
Conclusions......Page 46
References......Page 47
Patient Outcome Issues......Page 48
Residual Renal Function Issues......Page 49
Issues Related to Transplantation......Page 50
Cardiovascular Issues......Page 51
References......Page 52
Introduction......Page 54
Blood Temperature Modeling......Page 55
Conclusion......Page 56
References......Page 57
Physiological Demands upon Hemodialysis Technique......Page 58
Bacteriological Safety......Page 60
Clinical Experience......Page 61
Conclusion......Page 62
References......Page 63
Introduction......Page 64
Sodium Modeling by Conductivity in Paired Filtration Dialysis (PFD)......Page 65
Conductivity and Clinical Outcomes......Page 66
Appendix......Page 67
References......Page 68
Biomarkers of Phagocyte-Derived Oxidant Stress......Page 69
Inflammation and Phagocyte Activation in Uremia......Page 70
Measurement of Plasma Protein Oxidation in Response to Phagocyte-Derived Oxidants in Hypochlorous Acid......Page 71
Summary of in vitro Experiments......Page 72
Summary and Conclusions......Page 73
References......Page 74
Results......Page 75
Why Is Daily Hemodialysis Better than Conventional Hemodialysis?......Page 76
Is Daily Hemodialysis a Complex Therapy?......Page 77
References......Page 78
An Overview of the Kinetics of Variable Frequency Dialysis Therapy: The Rationale for Increased Dialysis Frequency......Page 80
Kinetics of Intermittent and Continuous Dialysis: Definitions of Equivalency between Intermittent and Continuous Clearance......Page 81
Clinical Evaluation of K[sub(pk), stdK and EKR......Page 82
Problems with Kinetic Evaluation of Short Dialysis and Low eKt/ V......Page 83
Conclusions and Recommendations......Page 84
References......Page 85
Interdialytic Weight Gain......Page 86
Blood Volume......Page 88
Dry Weight......Page 89
References......Page 90
Rationale for ADQI......Page 91
The First ADQI Conference......Page 92
ADQI Conference Methodology......Page 93
References......Page 95
Dialysis Decisions in the ICU: Current Practice......Page 96
Dialysis in the ICU: Suggested Approach......Page 98
Recommendations for Initial Choice of Dialysis in the ICU......Page 100
References......Page 101
Outside Advice......Page 102
Advice from Clinical Trialists......Page 103
Design of Clinical Trial Networks......Page 104
Conclusions......Page 105
References......Page 106
Background......Page 107
Method of Establishing a Dialysis Dose Measurement......Page 108
Results......Page 109
Discussion......Page 110
References......Page 112
Characteristics of the Blood Temperature Monitor......Page 114
Methods......Page 115
Results......Page 116
Discussion......Page 117
References......Page 119
Materials......Page 120
Results......Page 122
References......Page 123
The Changing Understanding of Toxins in Uremia ( Small Molecular Weight Proteins)......Page 124
Brief History of Sorbents in Uremia......Page 125
New Sorbent Design for Removal of Middle Molecular Weight Proteins, Polypeptides, etc.......Page 126
Conclusions......Page 127
References......Page 128
Introduction......Page 129
Results......Page 130
Discussion......Page 131
References......Page 132
Author Index......Page 133
C......Page 134
H......Page 135
M......Page 136
S......Page 137
W......Page 138